Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2000
08/17/2000WO2000024766A3 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
08/17/2000WO2000021527A3 Oxaliplatinum preparation packaging
08/17/2000WO2000020602A3 Delta 6 and delta 12 desaturases and modified fatty acid biosynthesis and products produced therefrom
08/17/2000WO2000015231A9 Adenosine a3 receptor modulators
08/17/2000WO2000014262A9 Methylation of plasmid vectors
08/17/2000WO2000012076A9 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
08/17/2000WO2000009109A3 Pipecolic acid derivatives for vision and memory disorders
08/17/2000WO2000007627A3 Topical delivery systems for active agents
08/17/2000WO2000006133A3 Compositions for treating diseases associated with glycosaminoglycan-associated molecular interactions
08/17/2000WO2000005393A3 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)
08/17/2000WO1999064594A3 Genes and gene expression products that are differentially regulated in prostate cancer
08/17/2000DE19956568A1 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene
08/17/2000DE19906310A1 Use of 3-(1-(2-aralkyl-2-carboxyethyl)-1-cyclopentanecarboxamido)-2,3,4,5-tetrahydro-2-oxo-1H-benz(b)azepine-1-acetic acid derivatives for treating hypertension
08/17/2000DE19906290A1 Orally administered medicament for treating colon cancer comprises ursodesoxycholic acid in gastric fluid resistant coating to provide direct topical action at target site
08/17/2000DE19906152A1 Wirkstoffhaltige Laminate für Transdermalsysteme Active substance laminates for transdermal
08/17/2000DE19906096A1 Protein mit einem Heparin-bindenden Epitop Protein having a heparin-binding epitope
08/17/2000DE19905961A1 Use of estrogens to treat cardiac insufficiency and left ventricular dysfunction following myocardial infarction
08/17/2000DE19905880A1 Spray enthaltend Ubichinon Qn Spray containing ubiquinone Q n
08/17/2000DE19905879A1 Ubichinon Qn zur Behandlung von Schmerzen Ubiquinone Q n for the treatment of pain
08/17/2000CA2367575A1 Stimulating neutrophil function to treat inflammatory bowel disease
08/17/2000CA2366487A1 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
08/17/2000CA2363454A1 Use of proanthocyanidin
08/17/2000CA2363088A1 Methods for treating viral infections
08/17/2000CA2362883A1 Alkylating agents for treatment of cellular proliferation
08/17/2000CA2362707A1 Means for regulating hematopoietic differentiation
08/17/2000CA2362662A1 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
08/17/2000CA2362593A1 Pancreatic progenitor cells, methods and uses related thereto
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362577A1 Ubiquinone qnfor the treatment of pains
08/17/2000CA2362575A1 Spray containing ubiquinone qn
08/17/2000CA2362561A1 Prolonged release bioadhesive vaginal gel dosage form
08/17/2000CA2362525A1 Cyclic peptides and aids vaccines
08/17/2000CA2362400A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
08/17/2000CA2362392A1 Heterocyclic derivatives as inhibitors of factor xa
08/17/2000CA2362390A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000CA2362389A1 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation
08/17/2000CA2362375A1 Alkenyl and alkynyl compounds as inhibitors of factor xa
08/17/2000CA2362372A1 Tyrosine alkoxyguanidines as integrin inhibitors
08/17/2000CA2362295A1 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000CA2362272A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000CA2362147A1 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
08/17/2000CA2362135A1 Non-nucleoside reverse transcriptase inhibitors
08/17/2000CA2362109A1 Novel antisense inhibition of rad51
08/17/2000CA2361919A1 Lactam inhibitors of fxa and method
08/17/2000CA2361585A1 Method and composition for preventing surgical adhesions and tissue damage employing fluorinated polymers
08/17/2000CA2361428A1 Inhibitors of factor xa
08/17/2000CA2361335A1 Inhibiting formation of atherosclerotic lesions
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2360952A1 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
08/17/2000CA2360319A1 Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts
08/17/2000CA2360305A1 Lactam inhibitors of fxa and method
08/17/2000CA2360258A1 Felbamate derived compounds
08/17/2000CA2360233A1 Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
08/17/2000CA2360164A1 5-ht1f agonists
08/17/2000CA2359926A1 Antagonists of hmg1 for treating inflammatory conditions
08/17/2000CA2359687A1 Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
08/17/2000CA2359674A1 Chain-shortened polynucleotide and method for preparation thereof
08/17/2000CA2359660A1 16-hydroxyestratrienes as selective estrogens
08/17/2000CA2359475A1 Method for purifying a red fruit extract containing anthocyanosides
08/17/2000CA2298352A1 Use of 3-substituted stilbene derivatives as active deodorants in cosmetic compositions
08/16/2000EP1028118A1 Process for producing 3-cephem compounds
08/16/2000EP1028117A2 Novel protein: prenyl transferase inhibitors
08/16/2000EP1028114A1 Novel guanidine derivatives as inhibitors of cell adhesion
08/16/2000EP1028112A1 Phenylglycinolamides linked by a hetero-atom with antiatherosclerotic agents
08/16/2000EP1028111A1 Amide derivatives or salts thereof
08/16/2000EP1028110A1 Novel dihydronaphthalene compounds and process for producing the same
08/16/2000EP1027893A2 Alginate containing medicament and implant for treating fibrosis
08/16/2000EP1027892A2 Azithromycin combination for emesis control in dogs
08/16/2000EP1027891A2 Neuropeptide y antagonists
08/16/2000EP1027890A2 Homer a new target of treating psychiatric disorders
08/16/2000EP1027889A2 Ergolin derivates for transdermal application
08/16/2000EP1027888A2 Osmotic system for delivery of solid amorphous dispersions of drugs
08/16/2000EP1027887A2 Matrix controlled release device
08/16/2000EP1027834A1 Food composition comprising L-arginine
08/16/2000EP1027827A1 Disinfectant composition
08/16/2000EP1027443A2 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
08/16/2000EP1027440A1 Inhibitor protein of the wnt signal pathway
08/16/2000EP1027438A2 Novel cytokine receptors
08/16/2000EP1027432A2 RIBOZYMES TARGETED TO IL-15 mRNA
08/16/2000EP1027429A1 Jnk3 modulators and methods of use
08/16/2000EP1027365A2 Antitumour uridine analogues
08/16/2000EP1027363A2 Adenosine a1-receptor agonists
08/16/2000EP1027362A1 2-halo-6-o-substituted ketolide derivatives
08/16/2000EP1027361A1 6,11-bridged erythromycin derivatives
08/16/2000EP1027360A2 3-descladinose 6-o-substituded erythromycin derivatives
08/16/2000EP1027359A2 Monocyclic l-nucleosides, analogs and uses thereof
08/16/2000EP1027354A1 Phthalocyanine analogs
08/16/2000EP1027353A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
08/16/2000EP1027352A1 Carbapenem antibacterial compounds, compositions and methods of treatment
08/16/2000EP1027351A1 Phenanthroline derivatives
08/16/2000EP1027350A1 Aminomethyl-benzo a]quinolizidine derivatives, preparation and therapeutic applications for neurodegenrative diseases
08/16/2000EP1027349A1 Tetrahydrofuran phosphate- and hydroxy esters, as prodrugs for the corresponding antifungal agent
08/16/2000EP1027347A2 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them
08/16/2000EP1027345A1 Synthetic methods for polyphenols
08/16/2000EP1027342A1 Cyclopentene derivatives useful as antagonists of the motilin receptor
08/16/2000EP1027340A1 4, 5-diaryloxazole compounds
08/16/2000EP1027339A1 Method and reagents for n-alkylating ureides
08/16/2000EP1027338A2 New carboxylic acid derivatives, carrying amido side-chains; production and use as endothelin receptor antagonists
08/16/2000EP1027337A1 Integrin receptor antagonists
08/16/2000EP1027336A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
1 ... 6261 6262 6263 6264 6265 6266 6267 6268 6269 6270 6271 6272 6273 6274 6275 6276 6277 6278 6279 6280 6281 ... 7860